Patrícia Marques-Alves

Dr. Patrícia Marques-Alves

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2019 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
PMPatrícia Marques-Alves
Patrícia Marques-Alves
AMAna Vera Marinho
Ana Vera Marinho
RTRogério Teixeira
Rogério Teixeira
RBRui Baptista
Rui Baptista
GCGraça Castro
Graça Castro
LGLino Manuel Martins Gonçalves
Lino Manuel Martins Gonçalves
Background: There is limited information regarding left atrial (LA) mechanics in aortic valve stenosis (AS). We assessed LA mechanics in AS through speckle-tracking echocardiography (STE) according to severity and prognosis. Methods: We included 102 patients diagnosed with severe AS (sAS) and 80 patients with moderate AS (mAS), all with preserved ejection fraction and no coronary artery disease. LA mechanics and left ventricular global longitudinal strain (LV-GLS) were assessed by STE. The cohort was followed-up for a median of 30 (IQR 12.6–50) months, and outcomes were determined (combined outcome of HF, death, and aortic valve replacement). Results: In our sample set, values of LV-GLS (− 18.5% vs − 17.1, p = 0.025), E/e’ ratio (15.8 vs 18.4, p = 0.03), and global LA mechanics (LA ɛsys, 23% vs 13.8%, p < 0.001) were worse for sAS compared to those for mAS. However, LA ɛsys (AUC 0.85, 95% CI 0.78–0.90, p < 0.001), ɛe (AUC 0.83, 95% CI 0.75–0.88, p < 0.001), and ɛa (AUC 0.80, 95% CI 0.70–0.84, p < 0.001) were the best discriminators of sAS, with sensitivities higher than 85%. LA ɛsys showed a stronger correlation with both aortic valve area (r2 = 0.6, p < 0.001) and mean LV/aortic gradient (r2 = 0.55, p < 0.001) than LV-GLS (r2 = 0.3 and r2 = 0.25, p = 0.01). Either LV-GLS or LA ɛsys, but not the E/e’ ratio, TAPSE, or RV/RA gradient, were a significant predictors of the combined outcome. Conclusions: LA global strain was the best discriminator of severity, surpassing E/e’ ratio and LV-GLS, and a significant predictor of prognosis in AS.

11 November 2017 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
PMPatrícia Marques-Alves
Patrícia Marques-Alves
NENuno Espírito-Santo
Nuno Espírito-Santo
RBRui Baptista
Rui Baptista
RTRogério Teixeira
Rogério Teixeira
RMRui Martins
Rui Martins
MPMariano Pego
Mariano Pego

6 August 2019 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PMPatrícia Marques-Alves
Patrícia Marques-Alves
AMAna Vera Marinho
Ana Vera Marinho
CDCélia Domingues
Célia Domingues
RBRui Baptista
Rui Baptista
GCGraça Castro
Graça Castro
LGLino Gonçalves
Lino Gonçalves

1 April 2019 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
PMPatrícia Marques-Alves
Patrícia Marques-Alves
RBRui Baptista
Rui Baptista
CCCatarina Canha
Catarina Canha
FFFátima Franco
Fátima Franco
LSLèlita Santos
Lèlita Santos
MPMariano Pêgo
Mariano Pêgo
Systemic sclerosis (SSc) is a systemic autoimmune disease involving multiple organs. We present a rare case of SSc in which clinical manifestations of cardiac fibrosis occurred early in the disease course. We report the case of a 40-year-old Caucasian man, previously diagnosed with SSc, who presented with decompensated heart failure. Transthoracic echocardiography was remarkable for severe right ventricular systolic dysfunction, abnormal ventricular septal motion, severe functional tricuspid regurgitation and normal pulmonary artery systolic pressure. Left ventricular ejection fraction was 45%. Right heart catheterization revealed no signs of pulmonary hypertension. Cardiac magnetic resonance (CMR) showed diffuse myocardial infiltration, later confirmed as myocardial fibrosis by endomyocardial biopsy. Myocardial fibrosis is an important cause of early heart failure in SSc patients and is associated with poor prognosis. Echocardiography and CMR help establish the diagnosis and enable an appropriate therapeutic strategy to be developed in such cases.

8 January 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
PMPatrícia Marques-Alves
Patrícia Marques-Alves
LGLino Manuel Martins Gonçalves
Lino Manuel Martins Gonçalves
MJMaria Vidigal João
Maria Vidigal João
Hypertrophic cardiomyopathy (HCM) is a heterogeneous cardiac disease and one of its major challenges is the limited accuracy in stratifying the risk of sudden cardiac death (SCD). Positron emission tomography (PET), through the evaluation of myocardial blood flow (MBF) and metabolism using fluorodeoxyglucose (FDG) uptake, can reveal microvascular dysfunction, ischemia, and increased metabolic demands in the hypertrophied myocardium. These abnormalities are linked to several factors influencing disease progression, including arrhythmia development, ventricular dilation, and myocardial fibrosis. Fibroblast activation can also be evaluated using PET imaging, providing further insights into early-stage myocardial fibrosis. Conflicting findings underscore the need for further research into PET’s role in risk stratification for HCM. If PET can establish a connection between parameters such as abnormal MBF or increased FDG uptake and SCD risk, it could enhance predictive accuracy. Additionally, PET holds significant potential for monitoring therapeutic outcomes. The aim of this review is to provide a comprehensive overview of the most significant data on disease progression, risk stratification, and prognosis in patients with HCM using cardiac PET-CT imaging.

1 December 2019 in HeartRhythm Case Reports
Verified
Journal Article
Open access
PMPatrícia Marques-Alves
Patrícia Marques-Alves
PSPedro A. Sousa
Pedro A. Sousa
NANatália António
Natália António
SBSérgio Barra
Sérgio Barra
LELuís Elvas
Luís Elvas
LGLino Gonçalves
Lino Gonçalves